Recommended Antimicrobial Agents for the Treatment and
Postexposure Prophylaxis of Pertussis 2005 CDC Guidelines
Tejpratap Tiwari, M.D. Trudy V. Murphy M. D. John Moran M.D.
National Immunization Program, CDC The material in this report
originated in the National Immunization Program, Stephen L.
Cochi, MD, Acting Director; and the Epidemiology and
Surveillance Division, Alison C. Mawle, PhD, Acting Director.
Corresponding preparer: Tejpratap Tiwari, National Immunization
Program, CDC, 1600 Clifton Road NE, MS E-61, Atlanta, GA 30333.
Telephone: 404-639-8765; Fax: 404-639-8257; Email:
email@example.com. The recommendations in this report were
developed to broaden the spectrum of antimicrobial agents that
are available for treatment and postexposure prophylaxis of
pertussis. They include updated information on macrolide agents
other than erythromycin (azithromycin and clarithromycin) and
their dosing schedule by age group. Pertussis is an acute
bacterial infection of the respiratory tract that is caused by
Bord